Skip to main content
OpenTrials
Completed

NCT Number: NCT01147770

Prolongation of Progesterone Supplementation in Antagonist Cycles and Pregnancy Outcomes

The objective of this study is to evaluate the effect of the prolongation of luteal support on the ongoing pregnancy rate (beyond 12 weeks of gestation )in recFSH/GnRH antagonist cycles.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Infertility Genital Diseases Urogenital Diseases

Age range

18 year–39 year

Sex eligibility

Female

Study type

Interventional

Phase

Phase 1 / Phase 2

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age equal or less than 39
  • Body mass index between 18-29 kg/m2
  • Presence of both ovaries
  • Basal hormonal values on day 2 of the cycle
  • Embryotransfer day3 or day5
  • 1 to 3 cycles

Exclusion criteria

  • Endometriosis stage 3
  • Polycystic ovarian syndrome
  • Frozen or testicular sperm

Treatment and study plan

Progesterone

Drug

duration

Other names: utrogestan

Primary outcomes

  1. ongoing pregnancy rate

    Time frame: up to 2 years

Sponsors and collaborators

Lead sponsor

Universitair Ziekenhuis Brussel

Other

Registry information

Official study title

The Effect of Progesterone Supplementation During Early Gestations in Patients Treated With Rec FSH/GnRH Antagonist:a Randomized Controlled Trial

Important dates

Study start
2008
Primary completion
2010
Study completion
2010
First posted
Jun 22, 2010
Registry last updated
Jul 3, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.